Crane Company Profile Avatar - Palmy Investing

Crane Company

Crane Company, together with its subsidiaries, manufactures and sells engineered industrial products in the Americas, Europe, the Middle East, Asia, and Australia. The company has four business segments: Aerospace & Electronics, Process Flow Technologies…
Industrial - Machinery
US, Stamford [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 100% Best
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -10.97 76.67 86.11
Graham Fair Price 16.28 25.11 21.59
PEG -71.02 0.96 -3.30
Price/Book 10.64 5.48 4.95
Price/Cash Flow 88.66 -86.45 45.82
Prices/Earnings -12.75 29.68 34.02
Price/Sales 7.90 13.61 12.61
Price/FCF 88.66 -86.45 45.82
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 7.26 0.39 0.36
Operating Margin 25.97 0.16 0.13
ROA 26.57 0.03 0.02
ROE 0.04 0.05 26.80
ROIC 0.03 0.04 24.80
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.17 0.26 -35.51
Dividends QOQ < 0.005 0.13 1568.03
EBIT QOQ -0.12 0.34 172.99
EPS QOQ -0.10 0.31 201.03
FCF QOQ 0.68 -1.61 136.80
Revenue QOQ < 0.005 0.06 1051.06
Naive Interpretation member
03 - Financial Growth · Best
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 93.72 100.18 6.90
Days Sales Outstanding (DSO) 62.49 68.41 9.48
Inventory Turnover 0.96 0.90 -6.45
Debt/Capitalization 0.16 0.21 29.67
Quick Ratio 1.50 1.32 -12.06
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 23.86 24.64 3.27
Cash 5.79 3.85 -33.55
Capex -0.23 -0.16 30.12
Free Cash Flow 2.58 -1.56 -39.44
Revenue 9.37 9.92 5.89
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.34 2.18 -6.83
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -0.18 1.46 712.07
Naive Interpretation Member
06 - Financial Health · Bad
End of CR's Analysis
CIK: 25445 CUSIP: 224441105 ISIN: US2244081046 LEI: - UEI: -
Secondary Listings
None Beside CR